+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biodegradable Sinus Drug Stent System Market by Indication, Material Type, Drug Type, End User, Distribution Channel, Patient Age Group - Global Forecast to 2030- Product Image
Biodegradable Sinus Drug Stent System Market by Indication, Material Type, Drug Type, End User, Distribution Channel, Patient Age Group - Global Forecast to 2030- Product Image
Sale

Biodegradable Sinus Drug Stent System Market by Indication, Material Type, Drug Type, End User, Distribution Channel, Patient Age Group - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6080701
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Introducing the Biodegradable Sinus Stent Revolution

The advent of biodegradable sinus drug stent systems marks a pivotal moment in the management of chronic and postoperative sinus conditions. By combining sustained local drug delivery with scaffold support that naturally dissolves over time, these devices promise to alleviate inflammation, prevent polyp regrowth, and reduce the need for revision procedures. Clinicians and healthcare administrators alike recognize that this integrated approach addresses key limitations of traditional treatments, such as systemic side effects and patient noncompliance with intranasal sprays.

This executive summary distills the core findings of an extensive study on the market dynamics, technological breakthroughs, and competitive landscape shaping this evolving segment. Drawing on primary interviews with leading otolaryngologists, procurement directors, and industry experts, as well as comprehensive secondary research, the analysis explores how material innovations, regulatory shifts, and evolving reimbursement frameworks converge to create new growth pathways. As sinusitis prevalence continues to rise globally, the market for biodegradable stent systems is poised to transition from niche applications toward broader clinical adoption, thereby redefining standards of care.

Emerging Forces Reshaping Sinus Stent Therapeutics

Over the past five years, several transformative forces have converged to reshape the sinus drug stent landscape. Advances in polymer science have yielded next-generation materials such as polydioxanone blends and bioabsorbable copolymers that enhance drug elution profiles and mechanical strength. Concurrently, the integration of targeted small-molecule therapies-ranging from broad-spectrum antibiotics to potent corticosteroids-has enabled personalized intervention strategies tailored to individual disease phenotypes.

Regulatory pathways have evolved in parallel, with streamlined 510(k) clearances for combination devices facilitating accelerated market entry in North America and Europe. At the same time, heightened emphasis on health-economic outcomes is driving greater collaboration between manufacturers and payers to demonstrate cost-effectiveness through real-world evidence. Telehealth and digital patient monitoring technologies are also beginning to intersect with implantable devices, laying the groundwork for data-driven post-procedural care and remote adherence tracking. Together, these shifts are catalyzing a transition from generic sinus management toward a precision medicine paradigm that places sustained, localized therapy at its core.

Navigating 2025 US Tariff Changes on Stent Imports

In 2025, the implementation of new United States tariffs on select medical device components and raw materials has injected a fresh set of challenges into the market. Tariffs targeting imported polymers such as polyglycolic acid and specialized drug-eluting coatings have driven up material costs by as much as 8 to 12 percent for device manufacturers reliant on foreign suppliers. This cost pressure is further compounded by stepped-up enforcement of import regulations and evolving free trade agreements.

Manufacturers are responding by reconfiguring supply chains-shifting toward domestic resin production, consolidating vendor portfolios, and exploring alternative polymer sources to mitigate volatility. Some market leaders have renegotiated long-term contracts with U.S.-based chemical suppliers to secure price stability, while others are investing in localized extrusion and coating facilities. In parallel, procurement teams within hospital systems are recalibrating budget forecasts and exploring group purchasing arrangements to spread incremental costs. These adaptations underscore the critical importance of proactive strategic planning amid a shifting tariff environment.

Deep Dive into Segment-Level Dynamics

The market for biodegradable sinus drug stents can be dissected through multiple strategic lenses. When considering patient indication, the segment addressing chronic rhinosinusitis with nasal polyps exhibits a tiered demand profile: Grade 1 cases often require mild corticosteroid elution, whereas Grade 3 presentations benefit from higher-dose agents and reinforced polymer matrices. Cases without nasal polyps generate demand across mild, moderate, and severe categories, each necessitating calibration of drug load and stent dwell time. Postoperative management creates another dimension, with early postoperative applications focusing on anti-inflammatory bursts and late postoperative interventions emphasizing scar tissue prevention.

Material type further differentiates the competitive landscape. Polydioxanone variants command strong interest due to their balanced absorption kinetics, while polyglycolic acid systems appeal when rapid dissolution is prioritized. Polylactic acid formulations support extended elution windows, aligning with prolonged therapeutic regimens. Drug type segmentation reveals that antibiotic-eluting devices anchored by azithromycin and ciprofloxacin secure broad spectrum coverage in infected cases. Amphotericin B and fluconazole formulations address refractory fungal infections, and corticosteroid options like budesonide, fluticasone, and mometasone furoate remain the backbone for inflammatory control.

Analysis by end user shows ambulatory surgical centers driving early adoption based on procedural efficiency and same-day discharge protocols, while clinics leverage point-of-care convenience. Hospital settings demand comprehensive formulary integration and evidence of length-of-stay reduction. Distribution channels range from direct tenders with large health networks to hospital pharmacy procurement and retail pharmacy offerings for outpatient follow-ups. Finally, age group segmentation highlights that adult patients represent the majority of implantations, whereas geriatric and pediatric subgroups exhibit distinct safety and dosing considerations that influence design and labeling strategies.

Regional Performance Hotspots and Growth Drivers

Geographic variations shape adoption patterns and competitive intensity. In the Americas, robust reimbursement frameworks and high rates of outpatient sinus procedures support rapid uptake of combination stent systems. Market leaders are expanding their U.S. footprint through joint ventures with local distributors and deploying dedicated clinical education programs. In the Europe, Middle East & Africa region, heterogeneity in regulatory approval timelines and hospital tender cycles creates a mosaic of opportunity windows. Here, manufacturers often partner with established device firms to navigate country-specific pathways and align with regional pricing benchmarks.

Across the Asia-Pacific landscape, significant growth is driven by increasing investments in otolaryngology infrastructure in emerging markets and rising awareness of minimally invasive interventions. Japan and Australia serve as early adopters with advanced reimbursement protocols, while China and India present scale potential underpinned by growing surgical volumes and favorable government initiatives on local device production. Understanding the interplay between regulatory harmonization, payer priorities, and clinical practice norms in each region is essential to crafting differentiated market entry and expansion strategies.

Strategic Moves by Leading Market Players

Several vendors are shaping the competitive environment through targeted innovation and strategic alliances. One leading firm has secured a first-mover advantage in the United States by obtaining dual antibiotic and corticosteroid clearance, thereby offering a differentiated value proposition on infection prophylaxis and inflammation control. Another market participant has forged collaborations with polymer specialists to co-develop next-generation bioresorbable scaffolds featuring tunable degradation profiles.

A third company has invested heavily in clinical trials across Europe, generating robust health-economic evidence that underscores reductions in revision surgery rates and overall treatment costs. Meanwhile, nimble regional players in Asia-Pacific are capitalizing on local manufacturing incentives to offer cost-competitive single-drug systems tailored to national formularies. Across all fronts, strategic mergers and acquisitions continue to refocus portfolios toward high-growth niche applications, fostering a marketplace where agility and evidence-generation prowess are critical differentiators.

Actionable Strategies for Industry Stakeholders

Industry stakeholders must prioritize integrated development pipelines that align material science breakthroughs with evolving clinical needs. Investing in modular stent platforms capable of accommodating multiple drug classes will accelerate response to emerging pathophysiological insights. Concurrently, establishing strategic sourcing agreements with polymer producers in tariff-sensitive jurisdictions can safeguard margin stability and reduce exposure to trade policy fluctuations.

Engagement with payer bodies and hospital procurement committees should extend beyond simple pricing negotiations to co-create outcome-based contracting models. Demonstrating real-world reductions in revision rates and total cost of care will unlock broader reimbursement coverage and strengthen the value narrative. Additionally, companies can gain a competitive edge by deploying digital patient support tools-such as mobile apps for symptom tracking and follow-up reminders-that complement the implant and deepen post-market intelligence. Finally, expanding into underpenetrated markets through selective licensing partnerships or carve-outs enables rapid scale without diluting core focus on primary care settings.

Rigorous Methodology Underpinning the Analysis

This analysis draws on a rigorous multi-phase research framework. We initiated a comprehensive review of secondary sources including peer-reviewed journals, regulatory filings, and proprietary databases to map technological, clinical, and commercial trends. Primary research encompassed in-depth interviews with over 25 key opinion leaders across otolaryngology, material science, and health economics, supplemented by discussions with procurement officers at major health systems.

Quantitative data were triangulated through statistical modeling to validate segment assumptions and identify growth inflection points. A proprietary scoring matrix assessed vendor capabilities across innovation, clinical evidence, and commercial execution. The methodology also incorporated sensitivity analyses to stress-test tariff impacts, reimbursement shifts, and regional adoption rates. Internal workshops and peer reviews ensured analytical rigor, while editorial oversight confirmed clarity, coherence, and alignment with industry best practices.

Synthesis of Key Findings and Implications

The confluence of material innovations, regulatory support, and strategic collaborations has set the stage for rapid expansion of biodegradable sinus drug stent systems. As tariffs, reimbursement policies, and clinical evidence continue to evolve, the marketplace will reward organizations that balance agility with robust outcome demonstration. Synthesizing the insights within this report equips stakeholders to make informed decisions on R&D prioritization, market entry sequencing, and partnership selection.

By understanding segment-specific dynamics and regional growth drivers, industry participants can tailor their approaches to maximize clinical impact and commercial return. The findings underscore that success in this arena hinges on an integrated value-based narrative supported by real-world data, agile supply chain management, and purposeful engagement with payers and providers.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Indication
    • Chronic Rhinosinusitis With Nasal Polyps
      • Grade 1
      • Grade 2
      • Grade 3
    • Chronic Rhinosinusitis Without Nasal Polyps
      • Mild
      • Moderate
      • Severe
    • Postoperative Management
      • Early Postoperative
      • Late Postoperative
  • Material Type
    • Polydioxanone
    • Polyglycolic Acid
    • Polylactic Acid
  • Drug Type
    • Antibiotics
      • Azithromycin
      • Ciprofloxacin
    • Antifungals
      • Amphotericin B
      • Fluconazole
    • Corticosteroids
      • Budesonide
      • Fluticasone
      • Mometasone Furoate
  • End User
    • Ambulatory Surgical Centers
    • Clinics
    • Hospitals
  • Distribution Channel
    • Direct Tender
    • Hospital Pharmacy
    • Retail Pharmacy
  • Patient Age Group
    • Adult
    • Geriatric
    • Pediatric
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Medtronic plc
  • SinuSys Corporation
  • Poly-Med, Inc.
  • Jiangsu Aosaikang Medical Co., Ltd.
  • Polymedical SAS
  • Shenzhen Sinova Medical Co., Ltd.
  • CGBioSciences Co., Ltd.
  • Aerin Medical, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biodegradable Sinus Drug Stent System Market, by Indication
8.1. Introduction
8.2. Chronic Rhinosinusitis With Nasal Polyps
8.2.1. Grade 1
8.2.2. Grade 2
8.2.3. Grade 3
8.3. Chronic Rhinosinusitis Without Nasal Polyps
8.3.1. Mild
8.3.2. Moderate
8.3.3. Severe
8.4. Postoperative Management
8.4.1. Early Postoperative
8.4.2. Late Postoperative
9. Biodegradable Sinus Drug Stent System Market, by Material Type
9.1. Introduction
9.2. Polydioxanone
9.3. Polyglycolic Acid
9.4. Polylactic Acid
10. Biodegradable Sinus Drug Stent System Market, by Drug Type
10.1. Introduction
10.2. Antibiotics
10.2.1. Azithromycin
10.2.2. Ciprofloxacin
10.3. Antifungals
10.3.1. Amphotericin B
10.3.2. Fluconazole
10.4. Corticosteroids
10.4.1. Budesonide
10.4.2. Fluticasone
10.4.3. Mometasone Furoate
11. Biodegradable Sinus Drug Stent System Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Clinics
11.4. Hospitals
12. Biodegradable Sinus Drug Stent System Market, by Distribution Channel
12.1. Introduction
12.2. Direct Tender
12.3. Hospital Pharmacy
12.4. Retail Pharmacy
13. Biodegradable Sinus Drug Stent System Market, by Patient Age Group
13.1. Introduction
13.2. Adult
13.3. Geriatric
13.4. Pediatric
14. Americas Biodegradable Sinus Drug Stent System Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Biodegradable Sinus Drug Stent System Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Biodegradable Sinus Drug Stent System Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Medtronic plc
17.3.2. SinuSys Corporation
17.3.3. Poly-Med, Inc.
17.3.4. Jiangsu Aosaikang Medical Co., Ltd.
17.3.5. Polymedical SAS
17.3.6. Shenzhen Sinova Medical Co., Ltd.
17.3.7. CGBioSciences Co., Ltd.
17.3.8. Aerin Medical, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET MULTI-CURRENCY
FIGURE 2. BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET MULTI-LANGUAGE
FIGURE 3. BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY GRADE 1, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY GRADE 2, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY GRADE 3, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MILD, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MODERATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY SEVERE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY EARLY POSTOPERATIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY LATE POSTOPERATIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYDIOXANONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY AZITHROMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CIPROFLOXACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY AMPHOTERICIN B, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY FLUCONAZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY BUDESONIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY FLUTICASONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MOMETASONE FUROATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 77. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 79. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 80. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 81. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 82. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 83. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 84. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 85. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 86. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 89. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 91. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 92. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 93. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 94. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 95. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 96. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 97. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 98. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 150. GERMANY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 151. GERMANY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 152. GERMANY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 153. GERMANY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 154. GERMANY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 155. GERMANY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 156. GERMANY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 157. GERMANY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 158. GERMANY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 159. GERMANY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. GERMANY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. GERMANY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 162. FRANCE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 163. FRANCE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 164. FRANCE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 165. FRANCE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 166. FRANCE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 167. FRANCE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 168. FRANCE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 169. FRANCE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 170. FRANCE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 171. FRANCE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. FRANCE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. FRANCE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 186. ITALY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 187. ITALY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 188. ITALY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 189. ITALY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 190. ITALY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 191. ITALY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 192. ITALY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 193. ITALY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 194. ITALY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 195. ITALY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. ITALY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. ITALY BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 198. SPAIN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 199. SPAIN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 200. SPAIN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 201. SPAIN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 202. SPAIN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 203. SPAIN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 204. SPAIN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 205. SPAIN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 206. SPAIN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 207. SPAIN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. SPAIN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. SPAIN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 224. SAUDI ARABIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 234. SOUTH AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 246. DENMARK BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 247. DENMARK BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 248. DENMARK BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 249. DENMARK BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 250. DENMARK BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 251. DENMARK BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 252. DENMARK BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 253. DENMARK BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 254. DENMARK BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 255. DENMARK BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. DENMARK BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. DENMARK BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 270. QATAR BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 271. QATAR BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 272. QATAR BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, 2018-2030 (USD MILLION)
TABLE 273. QATAR BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 274. QATAR BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MIL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biodegradable Sinus Drug Stent System market report include:
  • Medtronic plc
  • SinuSys Corporation
  • Poly-Med, Inc.
  • Jiangsu Aosaikang Medical Co., Ltd.
  • Polymedical SAS
  • Shenzhen Sinova Medical Co., Ltd.
  • CGBioSciences Co., Ltd.
  • Aerin Medical, Inc.

Related Topics

Related Reports

Biodegradable Metal Vascular Stent Market by End User, Application, Distribution Channel, Product, Material - Global Forecast to 2030 - Product Image

Biodegradable Metal Vascular Stent Market by End User, Application, Distribution Channel, Product, Material - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
Biodegradable Stents Market by Product Type, Material, Application, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Biodegradable Stents Market by Product Type, Material, Application, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Drug Eluting Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Drug Eluting Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Peripheral Drug Eluting Stent Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Peripheral Drug Eluting Stent Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Gastrointestinal Stent Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Gastrointestinal Stent Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 89 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.